Literature DB >> 6171028

Selective enhancement of human mononuclear leucocyte cytotoxic function by interferon.

I Kimber, M Moore.   

Abstract

The influence of type I interferon (IFN) on leucocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) has been examined in a system in which differential alloantibody sensitization of human erythrocyte target cells allows discrimination between lymphocyte and monocyte effector function. ADCC mediated by unfractionated mononuclear leucocyte populations was regularly enhanced by interferon pretreatment over a range of concentrations of the sensitizing antibody. The capacity of IFN-augmented reactivity was, however, removed with adherent cell depletion, suggesting that lymphocyte (K-cell) effectors are not modulated by IFN, even though such populations demonstrate IFN-potentiated natural killer (NK) reactivity against K562. These results suggest that monocyte and NK cell function but not K-cell activity was influenced by interferon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171028     DOI: 10.1111/j.1365-3083.1981.tb00147.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man.

Authors:  I Kimber; M D Stonard; D A Gidlow; Z Niewola
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

2.  Enhancement of human ADCC with interferon.

Authors:  R Warren; D Kalamasz; R Storb
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

3.  Divergence in activation by poly I:C of human natural killer and killer cells.

Authors:  B S Edwards; E C Borden; K Smith-Zaremba
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A.

Authors:  I Kimber; T Bakács; M Moore
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

5.  Enhanced K-cell activity in the peripheral blood of patients with malignant disease.

Authors:  T Bakács; P Czanik; I Kimber; G Ringwald; M Moore; E Abrahám
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.